Cloud River

Overall scoring
80
Popularity index
14858

Yunhe brand introduction

Yunhe logo

Yunnan Yunhe Pharmaceutical Co., Ltd., founded in 1958, is a high-tech enterprise integrating the development, manufacturing and sales of western medicine/Chinese patent medicine

Yunnan Yunhe Pharmaceutical Co., Ltd. (hereinafter referred to as Yunhe Pharmaceutical), formerly known as the state-owned Yunnan Province Gejiu City Pharmaceutical Factory, was founded in 1958, located in the world-famous tin capital - No. 1 Yunhe Avenue, Gejiu City, at the end of 2001 according to the modern enterprise system restructuring into a non-public enterprise. After years of hard work, Yunhe Pharmaceutical has developed into a national "GMP Certified Enterprise", "High-tech Enterprise", "Top 100 Traditional Chinese Medicine Enterprise Brands", "Provincial Enterprise Technology Center", "Provincial 100 Intellectual Property Demonstration Pilot Units", "Provincial Excellent Private Science and Technology Enterprises", "Provincial Innovative Enterprise Pilot Units", "Provincial Growth Small and Medium-sized Enterprises", "Provincial Small and Medium-sized Non-public Enterprises Listed and Cultivated Key Enterprises", "Provincial High-tech Listed Key Cultivation Enterprises".

Yunhe Pharmaceutical now covers an area of about 56 acres, with a construction area of about 55,987 square meters, a registered capital of 87.3 million yuan, total assets of 395.5 million yuan, and net assets of 159.58 million yuan. Yunhe Pharmaceutical has 2 wholly-owned subsidiaries, with a total of more than 300 employees, and has a nationwide marketing network and distributor team; It has a modern production line of 74 varieties and specifications of 11 dosage forms, including large-scale and small-volume injections, capsules, tablets, powders, granules, tinctures, solutions, syrup, mixtures, and APIs, which have passed the GMP standard certification, of which 22 varieties are listed in the National Essential Medicines List, and another 7 varieties are listed in the Yunnan Supplementary Catalogue of the National Essential Medicines List; It has 13 national invention patents and 4 design patent certificates. Relying on the unique treasure house of natural medicine in Yunnan Province and the authentic natural medicinal resources of Southeast Asia, Yunhe Pharmaceutical has excavated the secret recipes of traditional medicine and ethnic medicine with the essence of Chinese medicine, and has successively developed characteristic varieties and patented new drugs "Compound Dragon's Blood Exhaustion Capsule" with independent intellectual property rights and best-selling at home and abroad, such as "Hulisan Capsule", "Dragon's Blood Exhaustion Capsule", "Xiangguo Jianxiao Tablets".

Among them, the sales of the three major products of "Hulisan Capsule", "Dragon's Blood Exhaustion Capsule" and "Xiangguo Jianxiao Tablets" accounted for more than 91% of the total sales, especially the sales of the national traditional Chinese medicine protected variety "Hulisan Capsule" of the national traditional Chinese medicine protected variety "Hulisan Capsule" innovatively produced by the company inheriting the ancestral secret recipe of the Yi nationality in southern Yunnan reached 158 million yuan, enjoying a good reputation among patients across the country. The "Spruce Brand" trademark was rated as "Yunnan Famous Trademark", the "QQ Picture 20161122094724.jpg" trademark was rated as "China Famous Trademark", "Hu Lisan" (formerly Yunnan Rheumatism) was awarded the honorary certificate of "Excellent Quality of Export Products" by the Ministry of Foreign Trade and Economic Cooperation, "Dragon Blood Exhaustion Capsule" and "Hu Li San Capsule" were rated as "Yunnan Famous Brand" products, and "Compound Dragon Blood Exhaustion Capsule" was identified as "Key New Product of Yunnan Province". The main products have been successfully registered and sold in the United States, Russia and Singapore. At present, the company has entered a stage of rapid development.


This brand introduction page is provided with graphic information PP10013049 Collation compilation uploaded, last updated: 2025-05-05  Information error correction  disclaimer